Stille
199.5 SEK +1.53%4 investors are following this company
Stille develops, manufactures, and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology, and urology. The company's products are used among users on a global level. In addition to the core business, instrument management training is also offered. Stille was originally founded in 1841 and is headquartered in Eskilstuna.
Revenue
294.89M
EBIT %
15.24 %
P/E
37.57
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
STIL
Daily low / high price
196.5 / 204
SEK
Market cap
1.79B SEK
Turnover
214.71K SEK
Volume
1.1K
Financial calendar
General meeting
08.05.2024
Interim report
18.07.2024
Interim report
24.10.2024
Annual report
13.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Linc AB | 22.9 % | 22.9 % |
Impilo AB | 22.9 % | 22.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Stille AB: Interim Report Q1 2024
Notice of Annual General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools